{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:50:11Z","timestamp":1792810211969,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12020-015-0721-8","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T16:51:48Z","timestamp":1440435108000},"page":"305-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women"],"prefix":"10.1007","volume":"53","author":[{"given":"Marco","family":"Atteritano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Lasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"721_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"P.J. Meunier, C. Roux, E. Seeman, S. Ortolani, J.E. Badurski, T.D. Spector et al., The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350, 459\u2013468 (2004)","journal-title":"N. Engl. J. Med."},{"key":"721_CR2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","volume":"58","author":"JY Reginster","year":"2008","unstructured":"J.Y. Reginster, D. Felsenberg, S. Boonen, A. Diez-Perez, R. Rizzoli, M.L. Brandi et al., Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum. 58, 1687\u20131695 (2008)","journal-title":"Arthritis Rheum."},{"key":"721_CR3","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"J.Y. Reginster, E. Seeman, M.C. De Vernejoul, S. Adami, J. Compston, C. Phenekos et al., Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of Peripheral Osteoporosis (TROPOS) study. J. Clin. Endocrinol. Metab. 90, 2816\u20132822 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"721_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1359\/jbmr.071105","volume":"23","author":"E Seeman","year":"2008","unstructured":"E. Seeman, J.P. Devogelaer, R. Lorenc, T. Spector, K. Brixen, A. Balogh et al., Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J. Bone Miner. Res. 23, 433\u2013438 (2008)","journal-title":"J. Bone Miner. Res."},{"key":"721_CR5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-011-1847-z","volume":"23","author":"JY Reginster","year":"2012","unstructured":"J.Y. Reginster, J.M. Kaufman, S. Goemaere, J.P. Devogelaer, C.L. Benhamou, D. Felsenberg et al., Maintenance of antifracture efficacy over 10\u00a0years with strontium ranelate in postmenopausal osteoporosis. Osteoporos. Int. 23, 1115\u20131122 (2012)","journal-title":"Osteoporos. Int."},{"issue":"2","key":"721_CR6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2012-3048","volume":"98","author":"JM Kaufman","year":"2013","unstructured":"J.M. Kaufman, M. Audran, G. Bianchi, V. Braga, M. Diaz-Curiel, R.M. Francis et al., Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J. Clin. Endocrinol. Metab. 98(2), 592\u2013601 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"721_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1185\/03007995.2011.648758","volume":"28","author":"C Cooper","year":"2012","unstructured":"C. Cooper, J.Y. Reginster, R. Chapurlat, C. Christiansen, H. Genant, N. Bellamy et al., Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Curr. Med. Res. Opin. 28, 231\u2013239 (2012)","journal-title":"Curr. Med. Res. Opin."},{"key":"721_CR8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2013-203989","volume":"74","author":"JP Pelletier","year":"2015","unstructured":"J.P. Pelletier, C. Roubille, J.P. Raynauld, F. Abram, M. Dorais, P. Delorme et al., Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann. Rheum. Dis. 74, 422\u2013429 (2015)","journal-title":"Ann. Rheum. Dis."},{"key":"721_CR9","unstructured":"Protelos. Summary of Product Characteristics. Servier Labs. http:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/displaydoc.asp?documentid=15410 . Accessed 21 Aug 2006"},{"key":"721_CR10","unstructured":"EMEA Protelos Scientific Discussion (2005), http:\/\/www.emea.eu.int\/humandocs\/PDFs\/EPAR\/protelos\/121604en6.pdf . Accessed 21 Aug 2006"},{"key":"721_CR11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00198-013-2469-4","volume":"25","author":"B Abrahamsen","year":"2014","unstructured":"B. Abrahamsen, E.L. Grove, P. Vestergaard, Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos. Int. 25, 757\u2013762 (2014)","journal-title":"Osteoporos. Int."},{"issue":"1","key":"721_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1345\/aph.1H506","volume":"41","author":"M Halil","year":"2007","unstructured":"M. Halil, M. Cankurtaran, B.B. Yavuz, Z. Ulger, S. Piskinpasa, A. Gedik, I.C. Haznedaroglu, S. Kirazli, S. Ariogul, Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis. Ann. Pharmacother. 41(1), 41\u201345 (2007)","journal-title":"Ann. Pharmacother."},{"key":"721_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.archger.2010.11.024","volume":"54","author":"Z Ulger","year":"2012","unstructured":"Z. Ulger, E.I. Gurel, M. Halil, G. Oozen, I. Kalan, N. Seringec et al., Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects. Arch. Gerontol. Geriatr. 54, 218\u2013221 (2012)","journal-title":"Arch. Gerontol. Geriatr."},{"key":"721_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972)","journal-title":"Clin. Chem."},{"key":"721_CR15","unstructured":"European Medicines Agency. Assessment report\u2014periodic safety update report (EPAR\u2014Protelos-H-C-560-PSU31). (2014), www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000560\/WC500147168.pdf . Accessed 3 Feb 2014"},{"issue":"2","key":"721_CR16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00198-013-2469-4","volume":"25","author":"B Abrahamsen","year":"2014","unstructured":"B. Abrahamsen, E.L. Grove, P. Vestergaard, Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos. Int. 25(2), 757\u2013762 (2014)","journal-title":"Osteoporos. Int."},{"key":"721_CR17","unstructured":"European Medicines Agency European Medicines Agency recommends that Protelos\/Osseor remain available but with further restrictions (2014), http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Protelos_and_Osseor\/human_referral_prac_000025.jsp&mid=WC0b01ac05805c516f . Accessed 24 Feb 2014"},{"issue":"1","key":"721_CR18","first-page":"RA5","volume":"8","author":"SM Saadeddin","year":"2002","unstructured":"S.M. Saadeddin, M.A. Habbab, G.A. Ferns, Markers of inflammation and coronary artery disease. Med. Sci. Monit. 8(1), RA5\u2013RA12 (2002)","journal-title":"Med. Sci. Monit."},{"key":"721_CR19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","volume":"258","author":"WB Kannel","year":"1987","unstructured":"W.B. Kannel, P.A. Wolf, W.P. Castelli, D\u2019Aquistino RB Fibrinogen and the risk of cardiovascular disease: the Framingham study. J. Am. Med. Assoc. 258, 1183\u20131186 (1987)","journal-title":"J. Am. Med. Assoc."},{"key":"721_CR20","first-page":"178","volume":"37","author":"Y Shi","year":"2010","unstructured":"Y. Shi, Y. Wu, C. Bian, W. Zhang, J. Yang, G. Xu, Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome. Tex. Heart Inst. J. 37, 178\u2013183 (2010)","journal-title":"Tex. Heart Inst. J."},{"key":"721_CR21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.100.1.96","volume":"100","author":"WK Lagrand","year":"1999","unstructured":"W.K. Lagrand, C.A. Visser, W.T. Hermens, H.W. Niessen, F.W. Verheugt, G.J. Wolbink et al., C-reactive protein as a cardiovascular risk factor more than an epiphenomenon? Circulation 100, 96\u2013102 (1999)","journal-title":"Circulation"},{"key":"721_CR22","doi-asserted-by":"crossref","first-page":"17K","DOI":"10.1016\/S0002-9149(03)00774-4","volume":"92","author":"PM Ridker","year":"2003","unstructured":"P.M. Ridker, High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am. J. Cardiol. 92, 17K\u201322K (2003)","journal-title":"Am. J. Cardiol."},{"key":"721_CR23","first-page":"392","volume":"140","author":"G Ndrepepa","year":"2014","unstructured":"G. Ndrepepa, S. Braun, T. Tada, L. King, S. Cassese, M. Fusaro et al., Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease. Indian J. Med. Res. 140, 392\u2013400 (2014)","journal-title":"Indian J. Med. Res."},{"key":"721_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000099068","volume":"107","author":"H Tanriverdi","year":"2007","unstructured":"H. Tanriverdi, H. Evrengul, Y. Enli, O. Kuru, D. Seleci, S. Tanriverdi et al., Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology 107, 313\u2013320 (2007)","journal-title":"Cardiology"},{"key":"721_CR25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1253\/circj.CJ-12-0039","volume":"76","author":"MA Banos-Gonzalez","year":"2012","unstructured":"M.A. Banos-Gonzalez, E. Angles-Cano, G. Cardoso-Saldana, M.A. Pena-Duque, M.A. Martinez-Rios, B. Valente-Acosta et al., Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects. Circ. J. 76, 1953\u20131957 (2012)","journal-title":"Circ. J."},{"key":"721_CR26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","volume":"38","author":"N Khandanpour","year":"2009","unstructured":"N. Khandanpour, Y.K. Loke, F.J. Meyer, B. Jennings, M.P. Armon, Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur. J. Vasc. Endovasc. Surg. 38, 316\u2013322 (2009)","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"721_CR27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.5551\/jat.18929","volume":"20","author":"H Kumakura","year":"2013","unstructured":"H. Kumakura, H. Kanai, Y. Araki, Y. Hojo, S. Kasama, H. Sumino et al., Differences in brain natriuretic peptide and other factors between Japanese peripheral arterial disease patients with critical limb ischemia and intermittent claudication. J. Atheroscler. Thromb. 20, 798\u2013806 (2013)","journal-title":"J. Atheroscler. Thromb."},{"key":"721_CR28","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","volume":"120","author":"C Diehm","year":"2009","unstructured":"C. Diehm, J.R. Allenberg, D. Pittrow, M. Mahn, G. Tepohl, R.L. Haberl et al., Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120, 2053\u20132206 (2009)","journal-title":"Circulation"},{"key":"721_CR29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566524053766059","volume":"5","author":"EJ Dunn","year":"2005","unstructured":"E.J. Dunn, P.J. Grant, Type 2 diabetes: an atherothrombotic syndrome. Curr. Mol. Med. 5, 323\u2013332 (2005)","journal-title":"Curr. Mol. Med."},{"key":"721_CR30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/heart.86.6.605","volume":"86","author":"P Aukrust","year":"2001","unstructured":"P. Aukrust, T. Waehre, J.K. Damas, L. Gullestad, N.O. Solum, Inflammatory role of platelets in acute coronary syndromes. Heart 86, 605\u2013606 (2001)","journal-title":"Heart"},{"key":"721_CR31","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"G.K. Hansson, Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685\u20131695 (2005)","journal-title":"N. Engl. J. Med."},{"key":"721_CR32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM199703063361002","volume":"336","author":"KK Koh","year":"1997","unstructured":"K.K. Koh, R. Mincemoyer, M.N. Bui, G. Csako, F. Pucino, V. Guetta et al., Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N. Engl. J. Med. 336, 683\u2013690 (1997)","journal-title":"N. Engl. J. Med."},{"key":"721_CR33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","volume":"60","author":"A Zampetaki","year":"2012","unstructured":"A. Zampetaki, P. Willeit, L. Tilling, I. Drozdov, M. Prokopi, J.M. JM et al., Prospective study on circulating microRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60, 290\u2013299 (2012)","journal-title":"J. Am. Coll. Cardiol."},{"key":"721_CR34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12265-013-9459-y","volume":"6","author":"JL Januzzi Jr","year":"2013","unstructured":"J.L. Januzzi Jr, ST2 as a cardiovascular risk biomarker: from the bench to the bedside. J. Cardiovasc. Transl. Res. 6, 493\u2013500 (2013)","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"721_CR35","doi-asserted-by":"publisher","first-page":"971453","DOI":"10.1155\/2015\/971453","volume":"2015","author":"RK Upadhyay","year":"2015","unstructured":"R.K. Upadhyay, Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids. 2015, 971453 (2015). doi: 10.1155\/2015\/971453","journal-title":"J Lipids."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0721-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0721-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0721-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T13:59:44Z","timestamp":1599487184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0721-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0721-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]}}}